| Net Cash Provided by (Used in) Operating Activities |
$5,542,992 |
USD |
-79% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$7,652,477 |
USD |
85% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$20,919,987 |
USD |
-177% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$23,029,472 |
USD |
-2278% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$8,937,437 |
USD |
14% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$7,212,782 |
USD |
-59% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$654,467 |
USD |
-187% |
Q3 2025 |
Q3 2025 |
| Current Income Tax Expense (Benefit) |
$2,416,358 |
USD |
96% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$43,668,023 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$11,022,732 |
USD |
6.3% |
Q3 2025 |
Q3 2025 |